Dr Reddy's Laboratories (NYSE:RDY) reported its Q3 earnings results on Tuesday, January 30, 2024 at 01:30 PM.

Here's what investors need to know about the announcement.

Earnings

Dr Reddy's Laboratories beat estimated earnings by 25.32%, reporting an EPS of $0.99 versus an estimate of $0.79.

Revenue was up $42.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.23 which was followed by a 0.7% increase in the share price the next day.

Here's a look at Dr Reddy's Laboratories's past performance:

To track all earnings releases for Dr Reddy's Laboratories visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.